Duncan Williams Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Buy
6,218
+4
+0.1% +$932 0.36% 39
2026
Q1
$1.52M Sell
6,214
-171
-3% -$39.8K 0.42% 33
2025
Q4
$1.5M Buy
6,385
+4
+0.1% +$791 0.37% 36
2025
Q3
$1.18M Sell
6,381
-6
-0.1% -$1.03K 0.33% 48
2025
Q2
$976K Sell
6,387
-32
-0.5% -$4.92K 0.31% 53
2025
Q1
$1.06M Sell
6,419
-20
-0.3% -$3.13K 0.38% 45
2024
Q4
$931K Buy
6,439
+1,916
+42% +$297K 0.37% 46
2024
Q3
$733K Buy
4,523
+2,344
+108% +$373K 0.4% 50
2024
Q2
$318K Sell
2,179
-1,057
-33% -$157K 0.27% 52
2024
Q1
$512K Buy
+3,236
New +$515K 0.46% 40

Other funds holding JNJ

Duncan Williams Asset Management's JNJ Position: Q2 2026 in Review

Duncan Williams Asset Management increased its Johnson & Johnson (JNJ) stake by 0.06% in Q2 2026, buying an estimated $932 and bringing the position to 6,218 shares worth $1.58M. The position accounts for 0.36% of the portfolio, ranked #39.

Duncan Williams Asset Management first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Duncan Williams Asset Management held 6,218 shares of Johnson & Johnson worth $1.58M as of Q2 2026.
  • Duncan Williams Asset Management bought 4 Johnson & Johnson shares in Q2 2026, an estimated $932.
  • Johnson & Johnson made up 0.36% of Duncan Williams Asset Management's portfolio in Q2 2026, its #39 holding.
  • Duncan Williams Asset Management first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Duncan Williams Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.